Press releases

 Leader in data-driven medicine will discuss progress in the adoption of exome and...

As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot

Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON...

SOPHiA GENETICS leaders will talk onsite about the company’s cutting-edge SOPHiA DDM™ Platform

SOPHiA DDMTM deep-learnings algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers

SOPHiA GENETICS technology will help increase cancer research abilities

In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed  BOSTON and...

Strong growth momentum and efficient expense execution continues

SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on SOPHiA DDM™ HRD Solution 

BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fiscal 2023 before U.S. markets open on Tuesday, May 9, 2023. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CEST.

Recognition by the Swiss Biotech Association for SOPHiA GENETICS’ Outstanding Contributions as a Leader in Data-Driven Medicine

SOPHiA GENETICS  supports The University of Maryland Medical Center to advance their rare...